Showing results (21-30 of 119) with videos related to
Sort By:
Pageof 12
The Japanese Journal of Experimental Medicine|October 1, 1980
Kinetics of heterologous anti-rat tubular antigen antibody in rat kidneysS Hirohata, F ShimizuClinical and Experimental Rheumatology|October 3, 2009
Histopathology of the ruptured pulmonary artery aneurysm in a patient with Behçet's diseaseS Hirohata, H KikuchiCellular Immunology|September 1, 1993
Bidirectional modulation of human B cell stimulation by activated T cellsS Hirohata, S ShinoharaArthritis and Rheumatism|October 20, 1998
Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosusK Isshi, S HirohataCellular Immunology|February 1, 1993
Regulation of human B cell responsiveness by interferon-alpha: interferon-alpha-mediated suppression of B cell function is reversed through direct interactions between monocytes and B cellsH Oka, S HirohataJournal of Immunology (Baltimore, Md. : 1950)|May 1, 1995
The role of IL-10 in human B cell activation, proliferation, and differentiationK Itoh, S HirohataArthritis and Rheumatism|May 1, 1990
Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvementS Hirohata, T MiyamotoArthritis and Rheumatism|June 1, 1994
Comparative inhibitory effects of bucillamine and D-penicillamine on the function of human B cells and T cellsS Hirohata, P E LipskyJournal of Immunology (Baltimore, Md. : 1950)|April 15, 1989
T cell regulation of human B cell proliferation and differentiation. Regulatory influences of CD45R+ and CD45R- T4 cell subsetsS Hirohata, P E LipskyClinical Immunology and Immunopathology|January 1, 1993
Regulation of B cell function by bucillamine, a novel disease-modifying antirheumatic drugS Hirohata, P E LipskyPageof 12